- Home
- IPDN vs NCNA Comparison
IPDN vs NCNA Comparison
Compare IPDN & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPDN
- NCNA
- Stock Information
- Founded
- IPDN 2003
- NCNA 1997
- Country
- IPDN United States
- NCNA United Kingdom
- Employees
- IPDN N/A
- NCNA N/A
- Industry
- IPDN EDP Services
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- IPDN Technology
- NCNA Health Care
- Exchange
- IPDN Nasdaq
- NCNA Nasdaq
- Market Cap
- IPDN 5.4M
- NCNA 4.5M
- IPO Year
- IPDN 2013
- NCNA 2017
- Fundamental
- Price
- IPDN $1.81
- NCNA $0.04
- Analyst Decision
- IPDN
- NCNA Buy
- Analyst Count
- IPDN 0
- NCNA 2
- Target Price
- IPDN N/A
- NCNA $25.00
- AVG Volume (30 Days)
- IPDN 362.5K
- NCNA 301.1M
- Earning Date
- IPDN 08-12-2025
- NCNA 08-18-2025
- Dividend Yield
- IPDN N/A
- NCNA N/A
- EPS Growth
- IPDN N/A
- NCNA N/A
- EPS
- IPDN N/A
- NCNA N/A
- Revenue
- IPDN $6,508,349.00
- NCNA N/A
- Revenue This Year
- IPDN N/A
- NCNA N/A
- Revenue Next Year
- IPDN N/A
- NCNA N/A
- P/E Ratio
- IPDN N/A
- NCNA N/A
- Revenue Growth
- IPDN N/A
- NCNA N/A
- 52 Week Low
- IPDN $0.97
- NCNA $0.03
- 52 Week High
- IPDN $11.20
- NCNA $10.79
- Technical
- Relative Strength Index (RSI)
- IPDN 39.44
- NCNA 39.10
- Support Level
- IPDN $1.71
- NCNA $0.04
- Resistance Level
- IPDN $3.06
- NCNA $0.07
- Average True Range (ATR)
- IPDN 0.23
- NCNA 0.01
- MACD
- IPDN -0.13
- NCNA 0.00
- Stochastic Oscillator
- IPDN 7.41
- NCNA 25.00
About IPDN Professional Diversity Network Inc.
Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the TalentAlly Network segment, which maintains and operates job board software and hosts career fairs; the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization; the RemoteMore segment; and Corporate Overhead. The company generates majority of its revenue from TalentAlly Network Segment.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.